-
Je něco špatně v tomto záznamu ?
Protective effect of ginsenoside against acute renal failure and expression of tyrosine hydroxylase in the locus coeruleus
H. A. Zhang, M. Wang, J. Zhou, Q. Y. Yao, J. M. Ma, C. L. Jiang
Jazyk angličtina Země Česko
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- akutní poškození ledvin MeSH
- aplikace orální MeSH
- biologické markery krev MeSH
- časové faktory MeSH
- deprivace z nedostatku vody MeSH
- dusík močoviny v krvi MeSH
- financování organizované MeSH
- fosforylace MeSH
- ginsenosidy aplikace a dávkování farmakologie MeSH
- glutathion metabolismus MeSH
- glycerol MeSH
- imunohistochemie MeSH
- kreatinin krev MeSH
- krysa rodu rattus MeSH
- ledviny MeSH
- locus coeruleus enzymologie účinky léků MeSH
- malondialdehyd metabolismus MeSH
- mitogenem aktivovaná proteinkinasa 1 metabolismus MeSH
- mitogenem aktivovaná proteinkinasa 3 metabolismus MeSH
- modely nemocí na zvířatech MeSH
- ochranné látky aplikace a dávkování farmakologie MeSH
- peroxidace lipidů účinky léků MeSH
- potkani Sprague-Dawley MeSH
- tyrosin-3-monooxygenasa metabolismus MeSH
- upregulace MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
Acute renal failure (ARF) is mainly characterized by acute tubular necrosis. No significant change was found for mortality rates over the past few decades despite significant advances in supportive care. In recent years, great effort has been focused on traditional and herbal medicine, which is much less toxic than those agents conventionally used and which is nowadays considered as a novel therapeutic agent for ARF. However, the effect of ginsenosides (GS) administered orally on ARF has not been reported yet and little is known about its cellular and molecular mechanism. The purpose of the study is to investigate the protective effect of ginsenoside in rats with ARF on the changes of tyrosine hydroxylase immunoreactivity (TH-IR) as well as on the involvement of mitogen-activated protein kinases (MAPK) in the locus coeruleus. In our assay, glycerol-induced acute renal failure in rats was employed to study the protective effects of ginsenoside. Our results indicated that the treatment of ARF rats with ginsenosides for 48 h significantly reduced the serum blood urea nitrogen, creatinine level, and lipid peroxidation, restored the GSH level and the normal renal morphology. Immunohistochemistry showed that an obvious increase of TH-IR was further enhanced in ARF+GS group. The same effect was also observed in the changes of p-ERK1/2-IR in the locus coeruleus. Our results suggest that ginsenoside administered orally may have a strong renal protective effect against glycerol-induced ARF, and ginsenoside can also activate the brain catecholaminergic neurons in the locus coeruleus. Our future attention will be focused to the question whether there is a correlation between the renal protective effect of ginsenosides against acute renal failure and the activation of tyrosine hydroxylase in the locus coeruleus.
Citace poskytuje Crossref.org
Lit.: 39
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10013107
- 003
- CZ-PrNML
- 005
- 20111210173637.0
- 008
- 100601s2010 xr e eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.931650 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Zhang, H. A.
- 245 10
- $a Protective effect of ginsenoside against acute renal failure and expression of tyrosine hydroxylase in the locus coeruleus / $c H. A. Zhang, M. Wang, J. Zhou, Q. Y. Yao, J. M. Ma, C. L. Jiang
- 314 __
- $a Department of Physiology, Dalian Medical University, Dalian
- 504 __
- $a Lit.: 39
- 520 9_
- $a Acute renal failure (ARF) is mainly characterized by acute tubular necrosis. No significant change was found for mortality rates over the past few decades despite significant advances in supportive care. In recent years, great effort has been focused on traditional and herbal medicine, which is much less toxic than those agents conventionally used and which is nowadays considered as a novel therapeutic agent for ARF. However, the effect of ginsenosides (GS) administered orally on ARF has not been reported yet and little is known about its cellular and molecular mechanism. The purpose of the study is to investigate the protective effect of ginsenoside in rats with ARF on the changes of tyrosine hydroxylase immunoreactivity (TH-IR) as well as on the involvement of mitogen-activated protein kinases (MAPK) in the locus coeruleus. In our assay, glycerol-induced acute renal failure in rats was employed to study the protective effects of ginsenoside. Our results indicated that the treatment of ARF rats with ginsenosides for 48 h significantly reduced the serum blood urea nitrogen, creatinine level, and lipid peroxidation, restored the GSH level and the normal renal morphology. Immunohistochemistry showed that an obvious increase of TH-IR was further enhanced in ARF+GS group. The same effect was also observed in the changes of p-ERK1/2-IR in the locus coeruleus. Our results suggest that ginsenoside administered orally may have a strong renal protective effect against glycerol-induced ARF, and ginsenoside can also activate the brain catecholaminergic neurons in the locus coeruleus. Our future attention will be focused to the question whether there is a correlation between the renal protective effect of ginsenosides against acute renal failure and the activation of tyrosine hydroxylase in the locus coeruleus.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a aplikace orální $7 D000284
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a dusík močoviny v krvi $7 D001806
- 650 _2
- $a kreatinin $x krev $7 D003404
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a ginsenosidy $x aplikace a dávkování $x farmakologie $7 D036145
- 650 _2
- $a glutathion $x metabolismus $7 D005978
- 650 _2
- $a glycerol $7 D005990
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a ledviny $7 D007668
- 650 _2
- $a akutní poškození ledvin $7 D058186
- 650 _2
- $a peroxidace lipidů $x účinky léků $7 D015227
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a malondialdehyd $x metabolismus $7 D008315
- 650 _2
- $a mitogenem aktivovaná proteinkinasa 1 $x metabolismus $7 D019950
- 650 _2
- $a mitogenem aktivovaná proteinkinasa 3 $x metabolismus $7 D048052
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a ochranné látky $x aplikace a dávkování $x farmakologie $7 D020011
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a tyrosin-3-monooxygenasa $x metabolismus $7 D014446
- 650 _2
- $a upregulace $7 D015854
- 650 _2
- $a deprivace z nedostatku vody $7 D014868
- 650 _2
- $a locus coeruleus $x enzymologie $x účinky léků $7 D008125
- 700 1_
- $a Wang, M.
- 700 1_
- $a Zhou, J.
- 700 1_
- $a Yao, Q. Y.
- 700 1_
- $a Ma, J. M.
- 700 1_
- $a Jiang, C. L.
- 773 0_
- $w MED00003824 $t Physiological research $g Roč. 59, č. 1 (2010), s. 61-70 $x 0862-8408
- 856 41
- $u http://www.biomed.cas.cz/physiolres/pdf/59/59_61.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 8
- 990 __
- $a 20100601135354 $b ABA008
- 991 __
- $a 20101123155353 $b ABA008
- 999 __
- $a ok $b bmc $g 741232 $s 604715
- BAS __
- $a 3
- BMC __
- $a 2010 $b 59 $c 1 $d 61-70 $m Physiological research $x MED00003824
- LZP __
- $a 2010-15/mkme